Nexavar (sorafenib) — Medica
Bone cancer (recurrent chordoma or osteosarcoma)
Initial criteria
- age ≥ 18 years
- recurrent chordoma OR osteosarcoma with prior systemic chemotherapy (e.g., cisplatin, doxorubicin, methotrexate, ifosfamide)
Approval duration
1 year